Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

HomeAll NewsMost read newsBusiness Leaders Biography 
Portrait de Helge Lubenow
Age : 53
Public asset : 2,737 USD
Linked companies : Biofrontera AG - Epigenomics AG
Summary 
Helge Lubenow founded Agos Consulting. Currently, Dr. Lubenow is Chief Executive Officer for ProteoMediX AG. Dr. Lubenow is also on the board of 5 other companies.

She previously occupied the position of Managing Director at tesa Labtec GmbH and Senior Vice President at QIAGEN GmbH.

Dr. Lubenow received an undergraduate degree from the University of Giessen and a doctorate from Universitńt zu K÷ln.


Current positions of Helge Lubenow 
NameTitle Since
Biofrontera AG
(Pharmaceuticals)
Member-Supervisory Board 2021
Epigenomics AG
(Biotechnology & Medical Research)
Member-Supervisory Board 2016
ProteoMediX AG Chief Executive Officer 2017
Indical Bioscience GmbH Director -
Indical Topco AB Member-Supervisory Board -
Avelo AG Director -


Helge Lubenow: Personal Network 
Most Read News 
11/20Buffett's Berkshire boosts stakes in Japan's five biggest trading houses
RE
11/17Brazil's Buffett-backed StoneCo nearly doubles profits on more users, bigger prices
RE
11/23Berkshire Hathaway says Warren Buffett donates shares to family charities
RE
11/30Meta's Zuckerberg says some of Elon Musk's Twitter content approach 'might work'
RE
11/18Gates Foundation pledges $7 billion for Africa as Ukraine war diverts donor cash
RE
11/17After Elon Musk's ultimatum, Twitter employees start exiting
RE
11/18Musk's pay trial asks if Tesla's growth justifies $56 billion compensation
RE
11/30Interpol confirms red notice for Angolan billionaire Isabel dos Santos
RE
08:46aSalesforce shares tumble after surprise exit of co-CEO Taylor
RE
11/30Juventus has no requirement of additional capital, says Exor's Elkann
RE
More news


© 2022 People and Ownership :   
Helge Lubenow : Connections